OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
Jinrui Zhang, Ge Zhang, Wenjing Zhang, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 11, pp. 2247-2261
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma
Yanan Cui, Jun Li, Pengpeng Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 38

Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy
Yiwei Zhang, Yujun Zhang, Jingjing Song, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111876-111876
Closed Access | Times Cited: 9

Orlistat facilitates immunotherapy via AKT-FOXO3a-FOXM1-mediated PD-L1 suppression
Qingyun Tang, Jinghong Li, Lianhua Zhang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e008923-e008923
Open Access | Times Cited: 1

Hybrid Nanoparticle System Integrating Tumor-Derived Exosomes and Poly(amidoamine) Dendrimers: Implications for an Effective Gene Delivery Platform
Ashita Nair, Kaila Javius-Jones, Jason Bugno, et al.
Chemistry of Materials (2023) Vol. 35, Iss. 8, pp. 3138-3150
Closed Access | Times Cited: 21

RBMS1 Coordinates with the m6A Reader YTHDF1 to Promote NSCLC Metastasis through Stimulating S100P Translation
Yu Sun, Dan Chen, Siwen Sun, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 8

N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment
Zhiyun Duan, Runhan Shi, Bo Gao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7

Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6

Enzyme-catalyzed electrochemical aptasensor for ultrasensitive detection of soluble PD-L1 in breast cancer based on decorated covalent organic frameworks and carbon nanotubes
Yue Zhang, Shuyi Chen, Jie Ma, et al.
Analytica Chimica Acta (2023) Vol. 1282, pp. 341927-341927
Closed Access | Times Cited: 15

G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC‐I via PI3K/Akt Activation in Bladder Cancer
X.F. Steven Zheng, Jiawei Chen, Minhua Deng, et al.
Advanced Science (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 13

Genome-wide associations with longevity and reproductive traits in U.S. rangeland ewes
Jamin Smitchger, J. B. Taylor, Michelle R. Mousel, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 5

A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma
Xinyu Guo, Tianming Cui, Linmao Sun, et al.
Cell Death and Differentiation (2024)
Closed Access | Times Cited: 5

USP19 deficiency enhances T-cell-mediated antitumor immunity by promoting PD-L1 degradation in colorectal cancer
Feng Shi, Li Gui, Yi Liu, et al.
Pharmacological Research (2025) Vol. 214, pp. 107668-107668
Open Access

RBMS1 promotes the proliferation of glioma cells via regulation of the c-Myc–SSH1 axis
Shen Gu, Weining Wu, Chao Wu, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151586-151586
Closed Access

RBMS1-HSPA8 axis activation drives head and neck squamous cell carcinoma progression
Xinghong Yin, Meng Luo, Xiaojun Zha, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access

Disruption of RBMS3 suppresses PD-L1 and enhances antitumor immune activities and therapeutic effects of auranofin against triple-negative breast cancer
Yuting Zhou, Zhongping Liang, Yingjie Xia, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110260-110260
Closed Access | Times Cited: 17

circATAD2 mitigates CD8+ T cells antitumor immune surveillance in breast cancer via IGF2BP3/m6A/PD-L1 manner
Zhiling Zhang, Wenjie Huo, Jie Li
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 7
Open Access | Times Cited: 3

Increased ANKRD1 Levels in Early Senescence Mediated by RBMS1-Elicited ANKRD1 mRNA Stabilization
Chang Hoon Shin, Martina Rossi, Carlos Anerillas, et al.
Molecular and Cellular Biology (2024) Vol. 44, Iss. 5, pp. 194-208
Closed Access | Times Cited: 3

Regulation of PD-L1 glycosylation and advances in cancer immunotherapy
Te-An Lee, En-Yun Tsai, Shou-Hou Liu, et al.
Cancer Letters (2025), pp. 217498-217498
Closed Access

Weighted Gene Coexpression Network Analysis Identifies Neutrophil-Related Molecular Subtypes and Their Clinical Significance in Gastric Cancer
Chujia Chen, Yongfu Shao, Chengyuan Ye, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 397-418
Open Access

Targeting “don’t eat me” signal: breast cancer immunotherapy
Yue Gao, Xiaoyan Zhang, Mingqiang Ding, et al.
Breast Cancer Research and Treatment (2025)
Closed Access

Lipid acid metabolism reprogramming nanoagent induces ferroptosis storm and cGAS-STING activation for metal-immunotherapy of triple negative breast cancer
Dawei Zhou, Gaorui Zhang, J. Zhu, et al.
Chemical Engineering Journal (2025), pp. 162048-162048
Closed Access

Page 1 - Next Page

Scroll to top